Kawasaki Disease

About Kawasaki Disease

Kawasaki Disease(KD) is an official publication of the Korean Society of Kawasaki Disease (KSKD) and a peer-reviewed, open-access, multidisciplinary journal directed to physicians, other health care professionals and researchers who are interested in Kawasaki disease. Its regional focus is mainly Korea, but it also welcomes submissions from researchers and physicians all over the world. KD is concerned with the dissemination of knowledge on clinical, basic science and innovative methods related to Kawasaki disease or Kawasaki-like disease. The categories of manuscripts are original articles, reviews, editorials, case reports, other publications recognized by the Publications Committee. The journal is published twice a year on the official website https://www.e-kd.org. It is planned to be indexed in KCI, PubMEd, Scopus, Google Scholar, KoreaMed, KoreaMed Synapse and KoMCI, and easily available to wide international researchers.
Review

Jun 30, 2024

The Usefulness of Infliximab Treatment in the Acute Phase of Kawasaki Disease

Min Seob Song

Kawasaki Dis 2024;2(1):e1
https://doi.org/10.59492/kd.2024.2.1.e1

Infliximab, a tumor necrosis factor (TNF)-α blocking monoclonal antibody, is regarded as an effective and safe treatment modality for Kawasaki disease (KD). In clinical practice, infliximab administration in patients with KD has been associated with a shortened duration of fever and reduced hospital stays. Patients with KD who were treated with infliximab also showed improved outcomes in terms of resistance to intravenous immunoglobulin (IVIG) and coronary artery lesions (CALs). Many studies suggest that infliximab is beneficial not only as ...
Review

Jun 30, 2024

Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Adenitis (PFAPA) Syndrome: An Overview for Primary Care Practitioners
PFAPA 증후군: 일차 진료의를 위한 개요

Jin Lee, Soo-Young Lee, Dae Chul Jeong
이진, 이수영, 정대철

Kawasaki Dis 2024;2(1):e2
https://doi.org/10.59492/kd.2024.2.1.e2

Periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) syndrome is the most common autoinflammatory disease (AID) that causes recurrent fever in children. Patients with PFAPA present with essential symptoms such as periodic fever (usually every 28 days) and the PFAPA triad (stomatitis, pharyngitis, and adenitis) and additional symptoms such as abdominal pain, headache, rash, or arthralgia. PFAPA is diagnosed by (1) demonstrating the clinical manifestations included in the PFAPA criteria and (2) excluding other diseases that caus...
Review

Jun 30, 2024

Understanding Autoantibody Tests in Systemic Inflammatory Diseases
전신염증질환에서 시행되는 자가항체 검사의 이해

Soo-Young Lee, Kil Seong Bae, Jung Woo Rhim, Dae Chul Jeong
이수영, 배길성, 임정우, 정대철

Kawasaki Dis 2024;2(1):e3
https://doi.org/10.59492/kd.2024.2.1.e3

Autoantibodies are diagnostically useful markers of systemic inflammatory diseases, such as rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), systemic sclerosis (SSc), Sjögren’s syndrome (SjS), systemic vasculitis, and antiphospholipid syndrome (APS). Regardless of the role of autoantibodies in the pathogenesis of Kawasaki disease (KD), autoantibody testing may be performed in some KD patients due to the atypical presentation of the disease. This review describes four types of autoantibodies that KD practitioners often encount...
Case Report

Jun 30, 2024

Macrophage Activation Syndrome Complicating Kawasaki Disease: An Initial Presentation of Systemic Juvenile Idiopathic Arthritis
대식세포활성증후군이 합병된 가와사키병: 소아기특발성관절염의 초기 임상양상

Soo-Young Lee, Jung Woo Rhim, Dae Chul Jeong, Jin Han Kang
이수영, 임정우, 정대철, 강진한

Kawasaki Dis 2024;2(1):e4
https://doi.org/10.59492/kd.2024.2.1.e4

Kawasaki disease (KD) is one of the leading causes of macrophage activation syndrome (MAS) in children, so the possibility of developing MAS should be suspected in KD patients who do not show clinical improvement despite appropriate treatment. At the same time, since MAS is a hyperinflammatory phenomenon that can occur in various medical conditions that cause severe systemic inflammation, the possibility of coexisting undiagnosed underlying diseases must also be considered in children with MAS. Here, we report the case of a 16-month-old girl wi...

CURRENT ISSUE: Jun 2024, Vol. 2, No. 1

Review

The Usefulness of Infliximab Treatment in the Acute Phase of Kawasaki Disease

Min Seob Song

Kawasaki Dis 2024;2(1):e1
https://doi.org/10.59492/kd.2024.2.1.e1

HTML PDF PubReader TDM

Review

Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Adenitis (PFAPA) Syndrome: An Overview for Primary Care Practitioners
PFAPA 증후군: 일차 진료의를 위한 개요

Jin Lee, Soo-Young Lee, Dae Chul Jeong

이진, 이수영, 정대철

Kawasaki Dis 2024;2(1):e2
https://doi.org/10.59492/kd.2024.2.1.e2

HTML PDF PubReader TDM

Review

Understanding Autoantibody Tests in Systemic Inflammatory Diseases
전신염증질환에서 시행되는 자가항체 검사의 이해

Soo-Young Lee, Kil Seong Bae, Jung Woo Rhim, Dae Chul Jeong

이수영, 배길성, 임정우, 정대철

Kawasaki Dis 2024;2(1):e3
https://doi.org/10.59492/kd.2024.2.1.e3

HTML PDF PubReader TDM

Case Report

Macrophage Activation Syndrome Complicating Kawasaki Disease: An Initial Presentation of Systemic Juvenile Idiopathic Arthritis
대식세포활성증후군이 합병된 가와사키병: 소아기특발성관절염의 초기 임상양상

Soo-Young Lee, Jung Woo Rhim, Dae Chul Jeong, Jin Han Kang

이수영, 임정우, 정대철, 강진한

Kawasaki Dis 2024;2(1):e4
https://doi.org/10.59492/kd.2024.2.1.e4

HTML PDF PubReader TDM

MOST READ ARTICLES

Review Antithrombotic Therapy in Kawasaki Disease 가와사키병에서의 항혈전요법 Byung Won Yoo 류병원 Kawasaki Dis 2023;1(2):e15 https://doi.org/10.59492/kd.2023.1.2.e15 HTML PDF PubReader TDM Last 3 months views: 453	Original Article Epidemiology and Clinical Outcomes of Refractory Kawasaki Disease in South Korea Jong-Woon Choi, Gi Beom Kim Kawasaki Dis 2023;1(1):e7 https://doi.org/10.59492/kd.2023.1.1.e7 HTML PDF PubReader TDM Last 3 months views: 408
Review Kawasaki Disease and Multisystem Inflammatory Syndrome in Children 가와사키병과 소아다기관염증증후군 Eun Jung Shin 신은정 Kawasaki Dis 2023;1(1):e4 https://doi.org/10.59492/kd.2023.1.1.e4 HTML PDF PubReader TDM Last 3 months views: 349	Review Differentiation between Lymph-Node-First Presentation of Kawasaki Disease from Bacterial Cervical Lymphadenitis Jihye You Kawasaki Dis 2023;1(1):e5 https://doi.org/10.59492/kd.2023.1.1.e5 HTML PDF PubReader TDM Last 3 months views: 340
Review Historical Background of Kawasaki Disease in Korea 국내 가와사키병의 역사적 배경 Ji Whan Han 한지환 Kawasaki Dis 2023;1(1):e2 https://doi.org/10.59492/kd.2023.1.1.e2 HTML PDF PubReader TDM Last 3 months views: 325	Review Cardiac Outcomes of Multisystem Inflammatory Syndrome in Children Heirim Lee Kawasaki Dis 2023;1(2):e13 https://doi.org/10.59492/kd.2023.1.2.e13 HTML PDF PubReader TDM Last 3 months views: 324
Original Article Characteristics of Multisystem Inflammatory Syndrome in Children (MIS-C) with Hyperferritinemia 고페리틴혈증 동반 소아다기관염증증후군의 특징 Jung Woo Rhim, Beom Joon Kim, Soo-Young Lee, Dae Chul Jeong 임정우, 김범준, 이수영, 정대철 Kawasaki Dis 2023;1(2):e16 https://doi.org/10.59492/kd.2023.1.2.e16 HTML PDF PubReader TDM Last 3 months views: 304	Review Advancing Risk Stratification of Coronary Artery Aneurysms Caused by Kawasaki Disease Using Hemodynamics Analysis and Computational Fluid Dynamics Jongmin Seo Kawasaki Dis 2023;1(1):e6 https://doi.org/10.59492/kd.2023.1.1.e6 HTML PDF PubReader TDM Last 3 months views: 267
Case Report Kawasaki Disease Shock Syndrome and Macrophage Activation Syndrome: A Case Report 가와사키병 쇼크증후군과 대식세포 활성증후군: 증례보고 Beom Joon Kim, Danbi Kim, Kyoungsoon Cho, Jung Woo Rhim, Soo-Young Lee, Dae Chul Jeong 김범준, 김단비, 조경순, 임정우, 이수영, 정대철 Kawasaki Dis 2023;1(1):e11 https://doi.org/10.59492/kd.2023.1.1.e11 HTML PDF PubReader TDM Last 3 months views: 264	Original Article Plasma Exchange Treatment in Five Kawasaki Disease Patients Unresponsive to Intravenous Immunoglobulin 면역 글로불린 저항성을 보인 5명의 가와사키병 환아에서의 혈장 교환술을 통한 치료 Hyun Ok Jun, Eun-Jeong Shin, Jae Suk Baek, Jeong Jin Yu, Young-Hwue Kim, Jae-Kon Ko 전현옥, 신은정, 백재숙, 유정진, 김영휘, 고재곤 Kawasaki Dis 2023;1(1):e8 https://doi.org/10.59492/kd.2023.1.1.e8 HTML PDF PubReader TDM Last 3 months views: 249

MOST CITED ARTICLES

Case Report Kawasaki Disease Shock Syndrome and Macrophage Activation Syndrome: A Case Report 가와사키병 쇼크증후군과 대식세포 활성증후군: 증례보고 Beom Joon Kim, Danbi Kim, Kyoungsoon Cho, Jung Woo Rhim, Soo-Young Lee, Dae Chul Jeong 김범준, 김단비, 조경순, 임정우, 이수영, 정대철 Kawasaki Dis 2023;1(1):e11 https://doi.org/10.59492/kd.2023.1.1.e11 HTML PDF PubReader TDM Cited by 3	Review Kawasaki Disease and Multisystem Inflammatory Syndrome in Children 가와사키병과 소아다기관염증증후군 Eun Jung Shin 신은정 Kawasaki Dis 2023;1(1):e4 https://doi.org/10.59492/kd.2023.1.1.e4 HTML PDF PubReader TDM Cited by 2
Review Kawasaki Disease and Innate Immunity 가와사키병과 선천면역 Dae Chul Jeong 정대철 Kawasaki Dis 2023;1(1):e3 https://doi.org/10.59492/kd.2023.1.1.e3 HTML PDF PubReader TDM Cited by 1	Editorial A New Milestone: Inaugural Issue of Kawasaki Disease 창간사 Min Seob Song 송민섭 Kawasaki Dis 2023;1(1):e1 https://doi.org/10.59492/kd.2023.1.1.e1 HTML PDF PubReader TDM Cited by 0
Review Historical Background of Kawasaki Disease in Korea 국내 가와사키병의 역사적 배경 Ji Whan Han 한지환 Kawasaki Dis 2023;1(1):e2 https://doi.org/10.59492/kd.2023.1.1.e2 HTML PDF PubReader TDM Cited by 0	Review Differentiation between Lymph-Node-First Presentation of Kawasaki Disease from Bacterial Cervical Lymphadenitis Jihye You Kawasaki Dis 2023;1(1):e5 https://doi.org/10.59492/kd.2023.1.1.e5 HTML PDF PubReader TDM Cited by 0
Review Advancing Risk Stratification of Coronary Artery Aneurysms Caused by Kawasaki Disease Using Hemodynamics Analysis and Computational Fluid Dynamics Jongmin Seo Kawasaki Dis 2023;1(1):e6 https://doi.org/10.59492/kd.2023.1.1.e6 HTML PDF PubReader TDM Cited by 0	Original Article Epidemiology and Clinical Outcomes of Refractory Kawasaki Disease in South Korea Jong-Woon Choi, Gi Beom Kim Kawasaki Dis 2023;1(1):e7 https://doi.org/10.59492/kd.2023.1.1.e7 HTML PDF PubReader TDM Cited by 0
Original Article Plasma Exchange Treatment in Five Kawasaki Disease Patients Unresponsive to Intravenous Immunoglobulin 면역 글로불린 저항성을 보인 5명의 가와사키병 환아에서의 혈장 교환술을 통한 치료 Hyun Ok Jun, Eun-Jeong Shin, Jae Suk Baek, Jeong Jin Yu, Young-Hwue Kim, Jae-Kon Ko 전현옥, 신은정, 백재숙, 유정진, 김영휘, 고재곤 Kawasaki Dis 2023;1(1):e8 https://doi.org/10.59492/kd.2023.1.1.e8 HTML PDF PubReader TDM Cited by 0	Case Report Successful Treatment with Infliximab in Intravenous Immunoglobulin-Resistant Kawasaki Disease with High Procalcitonin Level: A Case Report Min Seob Song, Hye Su Hwang Kawasaki Dis 2023;1(1):e9 https://doi.org/10.59492/kd.2023.1.1.e9 HTML PDF PubReader TDM Cited by 0